Welcome to EpigenDx
EpigenDx is a genomic and epigenomic research company dedicated to providing superior products and laboratory services. Our technical expertise and focus on quality and rapid turnaround time have made us a dependable partner to our customers worldwide since 2006.
“Our experience with EpigenDx has been excellent – their technical staff will succeed even with difficult genomic regions.”
–Dr. Benjamin Tycko, MD/PhD
News and Publications
Publication in Stem Cells: Establishment of Reporter Lines for Detecting Fragile X Mental Retardation (FMR1) Gene Reactivation in Human Neural Cells.
Press Release: EpigenDx Inc. approved for KRAS mutation genetic testing.
Feature Article: Salivating Insights into the DNA Methylation Connection in Fetal Alcohol Syndrome
DNA Methylation Analysis
- 15 years of experience
- Measure the percent methylation of any CpG site in any target region
- Targeted bisulfite sequencing
- Pre-validated assays covering CpG-rich regions
- High, low, and premix methylation controls
- Comprehensive data validation and analysis
Targeted Next-Gen Bisulfite Sequencing
- DNA extraction, bisulfite treatment, multiplex PCR and library prep included
- High-throughput, targeted NGS techniques offer higher resolution than whole-genome bisulfite sequencing technologies
- Expert data analysis
- Send us your custom target regions, or choose from our pre-validated methylation panels